The clinical intervention trial to post stroke depression and apathy

UMIN ID: UMIN000008312

Registered date:08/07/2012

Basic Information

• Recruitment status: Recruiting
• Health condition(s) or Problem(s) studied: Post stroke depression and apathy
• Date of first enrollment: 2012/07/01
• Target sample size: 200
• Countries of recruitment: Japan
• Study type: Interventional

Intervention(s)

The group which accepts only PSD The paroxetine group
The group which accepts only PSD The milnaciplan group
The group which accepts only PSD The nicergolin group
The group which accepts both of PSD and apathy The milnaciplan group
The group which accepts both of PSD and apathy The amantadine group
The group which accepts both of PSD and apathy The nicergoline group
The group which accepts only apathy The amantadine group
The group which accepts only apathy The bromocriptine group
The group which accepts only apathy The nicergoline group

Outcome(s)

• Primary Outcome: FIM gain FIM efficacy
• Secondary Outcome: Zung Self-Rating Depression Scale gain Apathy Score gain SADQ-H10 gain Vitality index gain

Key inclusion & exclusion criteria

• Age minimum: 25years-old
• Age maximum: Not applicable
• Gender: Male and Female
• Exclude criteria: Contraindication of paroxetine/milnacipran/nicergoline/amantadine/bromocriptine

Related Information

• Primary Sponsor: Yuaikai Hospital
• Source(s) of Monetary Support: No